HomeBLAB • CNSX
add
Britannia Life Sciences Inc
Previous close
$0.070
Year range
$0.030 - $0.11
Market cap
11.36M CAD
Avg Volume
84.82K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.96M | -5.71% |
Operating expense | 748.23K | -36.39% |
Net income | -1.19M | -264.96% |
Net profit margin | -61.08 | -274.91% |
Earnings per share | — | — |
EBITDA | 593.37K | 58.59% |
Effective tax rate | -15.75% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 977.18K | -61.23% |
Total assets | 22.76M | -4.67% |
Total liabilities | 16.54M | 42.69% |
Total equity | 6.22M | — |
Shares outstanding | 162.25M | — |
Price to book | 7.00 | — |
Return on assets | 6.39% | — |
Return on capital | 10.62% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.19M | -264.96% |
Cash from operations | 89.97K | -84.53% |
Cash from investing | -93.70K | -205.35% |
Cash from financing | 193.14K | 140.90% |
Net change in cash | 234.82K | 168.16% |
Free cash flow | 523.51K | -23.58% |
About
Founded
2000
Headquarters
Website
Employees
28
